Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $249,988 - $411,526
2,470 New
2,470 $293,000
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $2.32 Million - $3.15 Million
19,608 New
19,608 $2.38 Million
Q1 2022

May 05, 2022

SELL
$126.46 - $235.05 $2.19 Million - $4.07 Million
-17,335 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $3.91 Million - $6.39 Million
17,335 New
17,335 $4.85 Million
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $1.07 Million - $1.94 Million
-8,270 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $902,918 - $1.54 Million
8,270 New
8,270 $1.08 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.